Teva: Warren Buffett Messed Things Up For Short-Sellers - Bloomberg
Teva: Warren Buffett Likely Made A Mistake Selling Shares | Seeking Alpha
Warren Buffett Q1 2018 stock buys and sells
Warren Buffett's Berkshire Hathaway increases stake in Apple
Why in the World Does Warren Buffett Like Teva Pharmaceutical? | The Motley Fool
Teva Surges After Warren Buffett's Berkshire Reports $358M Stake | BioSpace
Berkshire boosts Goldman, Teva stakes; buys more Apple
Why Warren Buffett's Berkshire loves loathed Israeli drug stock Teva
Warren Buffett Berkshire Hathaway Losing Millions on Teva Pharma - Jewish Business News
Why Warren Buffett's Still Gobbling Up Shares in This Generic Drugmaker | The Motley Fool
Berkshire Hathaway Dumps Teva Stock for a Loss - Jewish Business News
Warren Buffett boosts bet on ailing drugmaker Teva | The Times of Israel
Warren Buffett wagers big on Teva, and on Israel - Israel News - The Jerusalem Post
Warren Buffett ups stakes in Apple Inc and Teva Pharmaceutical Industries
Mock Warren Buffett? What's the Point? - RealMoney
Berkshire Hathaway Takes Position in Generic Drugmaker Teva | Ctech
Warren Buffett Berkshire Hathaway buys more Apple, Teva; sells Wells Fargo
:max_bytes(150000):strip_icc()/warren_buffett-5bfc322f46e0fb0051bf123c.jpg "Buffett's Berkshire Hathaway Adds Apple and Teva Shares, Dumps IBM")
Buffett's Berkshire Hathaway Adds Apple and Teva Shares, Dumps IBM
Teva shares jump 11 percent after Berkshire reports $358 million stake
Berkshire Hathaway Solidified its Teva Position in 2018 First Quarter | Ctech
Berkshire buys Teva, while Apple becomes top investment
Buffett ups stake in Teva $TEVA - TheStreet
Teva gets a boost as billionaire Buffett reports $358M stake | Fierce Pharma
Warren Buffett siger farvel til Teva | Dansk Aktionærforening
Warren Buffett boosts bet on ailing drugmaker Teva | The Times of Israel
Warren Buffett Just Made Life Way Harder for One Group of Investors
Warren Buffett ends drought with Berkshire's $11.6 bln Alleghany purchase | Reuters
Warren Buffett boosts Teva with $358 million investment for 1.8%
